Gossamer Bio, Inc. — Form 8-K
Filed August 26, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
On August 24, 2026, Gossamer Bio, Inc. filed an 8-K disclosing amendments to its articles of incorporation or bylaws and a change in fiscal year (Item 5.03). The specific terms, effective date, and business rationale for these amendments are not detailed in the filing index provided; the full text would require review of Exhibit 3.1.
Why this rating
Routine corporate governance amendment. No material dollar amounts, operational changes, or strategic shifts disclosed. Standard administrative action.
Extracted items
- 5.03 charter/bylaw change
- 9.01 exhibits
See more from August 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.